Validation of the NSABP/NRG Oncology 8-Gene Trastuzumab-benefit Signature in Alliance/NCCTG N9831

Pogue-Geile, KL; Song, N; Serie, DJ; Wang, Y; Gavin, PG; Kim, RS; Tanaka, N; Fumagalli, D; Taniyama, Y; Li, Z; Rastogi, P; Swain, SM; Mamounas, EP; Geyer, CE; Wolmark, N; Lucas, PC; Paik, S; Thompson, EA

JNCI CANCER SPECTRUM, 2020; 4 (5):

Abstract

Our objective was to validate the NSABP 8-gene trastuzumab-benefit signature, developed and initially validated in NRG Oncology/NSABP B-31 in Alliance......

Full Text Link